Suchergebnisse - "9NDF7JZ4M3"

PubPharm (4.971)

101

Lessons derived from post authorisation safety studies (ETNA-AF and XANTUS) on once daily direct oral anticoagulants for atrial fibrillation

enthalten in: International journal of cardiology | 2024

von Cemin, R. | Cappato, R.

102

Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors : monitoring of antidote effects

enthalten in: British journal of anaesthesia | 2024

von Tanaka, K. | Levy, J.

103

The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial : A US Perspective

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2024

von Lamy, A. | Eikelboom, J. | Tong, W. | +18

104

Calibration-free electrochemical sensor to monitor factor-Xa inhibitors at the point-of-care anticoagulation therapy

enthalten in: Talanta | 2024

von Mruthunjaya, A. | Chatelier, R. | Torriero, A.

105

The use of andexanet alpha in the Polish setting : An interdisciplinary protocol. Expert consensus statement of the Polish Cardiac Society

enthalten in: Kardiologia polska | 2024

von Kazimierczyk, E. | Dąbrowska, M. | Gierlotka, M. | +15

106

Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure

enthalten in: Cardiovascular therapeutics | 2024

von Yao, Y. | Li, Y. | Jin, Q. | +3

107

Direct oral anticoagulant concentrations and adherence in stroke patients

enthalten in: Basic & clinical pharmacology & toxicology | 2024

von Aakerøy, R. | Gynnild, M. | Løfblad, L. | +5

108

Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation

enthalten in: European journal of clinical investigation | 2024

von Wang, Y. | Chen, J. | Liao, S. | +3

109

Controversies in Stoppage of Antiplatelet and Anticoagulant Medications Prior to Oral Surgery

enthalten in: Dental clinics of North America | 2024

von Chan, M. | Sun, F. | Malakan, J.

110

An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics - A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients

enthalten in: International journal of pharmaceutics | 2024

von Romański, M. | Giebułtowicz, J. | Gniazdowska, E. | +8